St. Marianna University School of Medicine;Daiichi Sankyo Company, Limited
发明人:
申请号：
EP18741561.7
公开号：
EP3572095A1
申请日:
2018.01.18
申请国别(地区):
EP
年份:
2019
代理人:
摘要：
The present invention provides a pharmaceutical composition containing an inhibitor selected from the group consisting of an EZH1 inhibitor, an EZH2 inhibitor and an EZH1/2 dual inhibitor as an active ingredient, for use in treating HTLV-1-associated myelopathy. The present invention provides a pharmaceutical composition for use in treating HTLV-1-associated myelopathy, containing a 1,3-benzodioxole derivative or a pharmaceutically acceptable salt thereof.
